European Patent Office Grants Patent for BioCurex Inc.'s RECAF Blood Tests

March 26, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

RICHMOND, British Columbia, March 25, 2008 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) announced today that the European Patent Office (EPO) has granted the Company's patent claims for cancer diagnostic serum tests based on the RECAF marker.

Twitter
LinkedIn
Facebook
Email
Print